Propranolol labels and packages: Difference between revisions

Revision as of 22:52, 4 February 2014

Propranolol
Inderal LA^® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Propranolol
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Adapted from the FDA Package Insert.

@@ Line 3: / Line 3: @@
 {{CMG}}; {{AE}} {{AZ}}
+==Labels and Packages==
-<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = INDERAL LA (PROPRANOLOL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AKRIMAX PHARMACEUTICALS, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fce692df-1e68-465e-8dda-0cb01320608c | publisher =  | date =  |accessdate = }}</ref>
+{|
+|[[File:Inderal 60mg.JPG|600px|thumb]]
+|}
+{|
+|[[File:Inderal 80mg.JPG|600px|thumb]]
+|}
+{|
+|[[File:Inderal 120mg.JPG|600px|thumb]]
+|}
+{|
+|[[File:Inderal 160 mg.JPG|600px|thumb]]
+|}<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = INDERAL LA (PROPRANOLOL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AKRIMAX PHARMACEUTICALS, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fce692df-1e68-465e-8dda-0cb01320608c | publisher =  | date =  |accessdate = }}</ref>
 ==References==